By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.

Long-standing partnership as strong foundation for extended collaboration Expanded cooperation in global RISE with SAP transformation projects ...

The final four dividend stocks to buy and hold in 2025 are a mixed assortment. The common denominators between these stocks ...

Topical antifungals, although often effective, are being discouraged in the early treatment of seborrheic dermatitis now that ...

By Tom Loftus Kentucky Lantern Another $50,000 from tobacco giant v last month brings money raised to expand the Republican ...

BRUSSELS, January 6. /TASS/. The court of the Belgian city of Liege will hold a session to consider whether President of the European Commission (EC) Ursula von der Leyen has legal immunity against ...

These four S&P 500 stocks pay 6% and higher dividends, have Buy ratings at top Wall Street firms, and are offering excellent ...

Donald Trump’s allies have raised over $200 million to fund his inauguration, political operations, and presidential library.

Regeneron Pharmaceuticals is a strong investment with robust growth potential, fueled by FDA approvals and resilient market ...

Pfizer (NYSE: PFE) stock investors are curious about the valuation and prospects for the healthcare company. Stock prices used were the afternoon prices of Jan. 1, 2025. The video was published on Jan ...

The U.S. continues to charge significantly higher prices for prescription drugs compared with similarly wealthy countries.

Aetna is taking legal action against Pfizer, Novartis, Teva Pharmaceuticals and others, saying the list of drugmakers ...